Jerome D. Jabbour - 20 Dec 2022 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
President and CEO, Director
Signature
/s/ Keith A. Kucinski, attorney-in fact for Jerome D. Jabbour
Issuer symbol
MTNB
Transactions as of
20 Dec 2022
Net transactions value
$0
Form type
4
Filing time
22 Dec 2022, 10:20:42 UTC
Previous filing
15 Dec 2021
Next filing
15 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTNB Stock Option (right to Buy) Award $0 +1,988,300 $0.000000 1,988,300 20 Dec 2022 Common Stock 1,988,300 $0.5300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023.